Filgrastim Terminated Phase 1 Trials for Unspecified Adult Solid Tumor, Protocol Specific / Brain and Central Nervous System Tumors / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00003567Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
NCT00002948High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer